Moreover, glioblastoma patients could also be divided into two subgroups with different outcomes based on TRAF6 expression, i.e., the higher expression of TRAF6 was, the poorer prognosis of patients (DFS: P < 0.0001; OS: P < 0.0001; Figure 3G and 3H). This evidence concerns the gene TRAF6 and glioblastoma.